Introduction
Meibomian Gland Dysfunction (MGD) is a leading—and often overlooked—cause of dry eye. Studies and major reviews of the ocular surface report that most patients with dry eye have a significant meibomian gland component; addressing gland health is often the key to lasting symptom relief. Learn what MGD is, how it is diagnosed, and the practical treatments we use at Evolutionary Eye Care to restore comfort and ocular surface stability.
What is Meibomian Gland Dysfunction?
Meibomian glands are tiny oil-producing glands embedded in the eyelid margins. They secrete the lipid layer of the tear film (meibum), which slows tear evaporation and stabilizes the surface of the eye. In MGD, the glands become clogged, inflamed, or produce poor-quality oil. The result is a thinner, unstable tear film that evaporates too quickly—commonly called evaporative dry eye.
In plain terms: when the eyelid glands don’t release good oil, tears break up faster, the eye feels gritty, and inflammation follows. MGD is not simply “dryness”; it’s a dysfunction of tear-film lipid production that can vary in severity from mild discomfort to chronic, vision-limiting surface disease.
Symptoms and How MGD is Diagnosed
MGD symptoms can overlap with other forms of dry eye, so a careful evaluation is essential. Common complaints include:
- Intermittent blurry vision that improves with blinking
- Burning, stinging, or gritty sensation
- Excessive tearing (reflex tearing) despite a dry feeling
- Sensitivity to light and contact lens intolerance
- Heavy or crusty eyelid margins, particularly in the morning
At your visit we perform a focused exam rather than relying on symptoms alone. Typical diagnostic steps include:
- Slit-lamp examination of eyelid margin anatomy and signs of inflammation
- Meibomian gland expression to assess secretion quality and ease of flow
- Non‑contact meibography (imaging) to visualize gland structure and dropout
- Tear breakup time (TBUT) and ocular surface staining to evaluate tear stability and surface damage
- In select cases, tear osmolarity or inflammatory marker testing
These tests let us quantify gland dysfunction, identify associated eyelid disease (like blepharitis or rosacea), and create a personalized treatment plan. For a comprehensive overview of MGD and its role in dry eye, see the Tear Film & Ocular Surface Society (TFOS) DEWS II report: TFOS DEWS II.
Treatment Options: From Home Care to In‑Office Therapies
Treatment of MGD is individualized. Our goal is to improve gland function, reduce eyelid inflammation, and restore a stable tear film. A typical stepped approach includes conservative measures first, with in‑office procedures and prescription options for persistent or moderate-to-severe disease.
Standard and at‑home therapies
- Warm compresses and structured lid hygiene — heat softens meibum and helps clear blocked glands; regular, effective techniques are important for success.
- Lid massage and expression — performed at home or in the office to help express the glands.
- Lubricating drops (artificial tears) — to address symptoms while underlying inflammation is treated. Preservative-free options are generally preferred for frequent use.
- Dietary modification and supplements — omega‑3 fatty acids may help some patients, but results vary and should be discussed with your provider.
Prescription and interventional options
- Topical anti‑inflammatories (e.g., cyclosporine, lifitegrast) — reduce ocular surface inflammation that perpetuates MGD.
- Topical or oral antibiotics (e.g., topical azithromycin or systemic doxycycline) — used for their anti‑inflammatory and gland‑modifying properties in appropriate patients.
- In‑office gland expression or manual debridement — for stubborn gland obstruction when home care is insufficient.
- Low Level Light Therapy (LLLT) — a non‑invasive in‑office option we offer that uses specific light wavelengths to reduce eyelid inflammation and support improved gland function. LLLT is an adjunctive therapy; individual response varies and it is generally used as part of a comprehensive plan.
- Scleral contact lenses — for patients with significant ocular surface disease or corneal irregularity, scleral lenses vault the cornea and create a protective fluid reservoir. They can dramatically improve comfort and vision in severe cases but do not by themselves stop the biological progression of gland disease.
We do not use or recommend thermal systems (such as LipiFlow or TearCare) at our clinic; instead, we focus on the evidence-based combination of careful lid management, medication where appropriate, LLLT, and custom device use (including scleral lenses) when indicated.
What to Expect: Follow‑Up, Risks, and Realistic Outcomes
MGD typically requires ongoing management rather than a single “fix.” Some patients respond well to conservative care alone; others need repeat in‑office treatments and medications. At your first visit we will outline a realistic plan, explain likely timelines for symptom improvement, and set follow‑up intervals to monitor gland function and ocular surface health.
Important points about safety and limitations:
- Topical and oral medications have potential side effects—your provider will discuss risks and monitor therapy.
- Scleral lenses are medical devices that require expert fitting and maintenance; improper use increases infection risk, so regular follow-up is essential.
- No single therapy is universally curative; combination therapy tailored to the individual usually gives the best outcome.
Because MGD often coexists with other ocular or systemic conditions (for example, rosacea or autoimmune disease), we may coordinate care with your primary care physician or a dermatologist when appropriate.
Next Steps
If you have chronic dryness, fluctuating vision, eyelid crusting, or contact lens intolerance, an MGD-focused evaluation is an important first step. At Evolutionary Eye Care our doctors use detailed diagnostics and a range of treatments—especially Low Level Light Therapy and scleral lens support when appropriate—to help restore comfort and protect the ocular surface. Schedule an appointment at one of our Houston locations in Sugar Land, Webster, or Downtown Houston to begin an individualized treatment plan for MGD and dry eye.